Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT00284622
Other study ID # HTO-1
Secondary ID
Status Not yet recruiting
Phase Phase 2
First received January 31, 2006
Last updated January 28, 2009
Start date December 2009
Est. completion date December 2011

Study information

Verified date January 2009
Source Fowler Kennedy Sport Medicine Clinic
Contact J.. Robert Giffin, MD, FRCSC
Phone 519-661-2111
Email stdshg@uwo.ca
Is FDA regulated No
Health authority Canada: Health Canada
Study type Interventional

Clinical Trial Summary

It remains unknown if a concomitant arthroscopic knee debridement would increase the benefits of surgery (quality of life and functional ability) for young active patients with medial compartment OA of the knee and varus alignmen. This additional procedure has a low incidence of morbidity and would potentially allow for treatment of meniscal tears and articular damage, as well as joint lavage to remove debris and inflammatory factors. A trial is needed to determine whether HTO with concomitant knee arthroscopy will result in better overall outcomes for this patient group.The objective is to compare the quality of life, functional status, pain, and swelling of patients who undergo an HTO with or without a concomitant knee joint arthroscopy to address additional joint pathology


Description:

Arthroscopy for degenerative conditions of the knee is among the most widely employed orthopaedic procedures, but its effectiveness (like the effectiveness of many surgical operations) has never been proven in prospective trials. The evidence supporting the use of arthroscopy in treatment algorithms for knee OA comes largely from case series and cohort studies. These studies have shown that about 50% of patients report pain relief following the procedure. Predictors of poor outcome following arthroscopy include marked mal-alignment, restricted range of motion, advanced radiographic changes, and prior surgery. Improved outcomes are predicted by preoperative mechanical symptoms caused by loose bodies, meniscal tears, or radiographic evidence of mild articular degeneration.

The proposed study is a randomized clinical trial.

Each patient will undergo a preoperative MRI of their affected knee joint to identify existing pathology (e.g. meniscal tears, loose bodies, chondral flaps). The results of the MRI will not be revealed to physicians, patients or data collectors. This will ensure that we have information on the existing joint pathology within each group and that prognostic variables between groups were sufficiently balanced (i.e. comparable rates of similar pathology per group). The primary outcome measure is self-reported quality of life (WOMAC). Secondary measures include self-reported functional ability (LEFS), swelling, pain and frequency of analgesic use (patient diary), and general health (SF-36). Assessments will take place preoperatively and at 3, 6 and 12 months postoperatively.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 98
Est. completion date December 2011
Est. primary completion date December 2011
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- patients with medial compartment osteoarthritis as determined by clinical examination and plain radiographs.

- scheduled for an HTO

Exclusion Criteria:

1. Evidence of other significant knee pathology,

2. Active joint or systemic infection,

3. Major medical illness that would preclude undergoing surgery,

4. Patients who are unwilling or unable to be assessed according to study protocol for one year following surgery

5. Major psychiatric illness, developmental handicap or inability to read and understand the English language

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Factorial Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Procedure:
Arthroscopy
HTO with pre-scope

Locations

Country Name City State
Canada Fowler Kennedy Sport Medicine Clinic London Ontario

Sponsors (1)

Lead Sponsor Collaborator
Fowler Kennedy Sport Medicine Clinic

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary self-reported quality of life (WOMAC). 2 years No
Secondary self-reported functional ability (LEFS), 2 years No
Secondary swelling 2 years No
Secondary pain 2 yrs No
Secondary frequency of analgesic use (patient diary), 3 mths No
Secondary general health (SF-36). 2 yrs No
See also
  Status Clinical Trial Phase
Completed NCT01269944 - Effects of Osteotomies Around the Knee on Cartilage Glycosaminoglycan Content Using dGEMRIC Non-invasive Imaging N/A
Withdrawn NCT01614288 - High Tibial Osteotomy (HTO) With or Without Arthroscopy of the Knee Joint N/A